Caribou Biosciences (CRBU) Long-Term Investments (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Long-Term Investments data on file, last reported at $1.0 million in Q1 2026.

• Quarterly Long-Term Investments fell 74.89% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 74.89% YoY) and the FY2025 annual result came in at $3.5 million, down 91.2% from the prior year.
• Long-Term Investments retreated to $1.0 million in Q1 2026 per CRBU's latest filing, from $3.5 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $69.4 million in Q4 2022 and bottomed at $132000.0 in Q2 2025.
• The 5-year median for Long-Term Investments is $7.8 million (2023), against an average of $15.8 million.
• The widest annual swing landed in 2024, when Long-Term Investments jumped 545.43%; it then tumbled 99.74% in 2025.
• Tracing CRBU's Long-Term Investments over 5 years: stood at $69.4 million in 2022, then slumped by 88.82% to $7.8 million in 2023, then surged by 413.98% to $39.8 million in 2024, then slumped by 91.2% to $3.5 million in 2025, then sank by 71.44% to $1.0 million in 2026.
• Per Business Quant, the three latest CRBU Long-Term Investments figures stand at $1.0 million (Q1 2026), $3.5 million (Q4 2025), and $143000.0 (Q3 2025).

Peer Comparison